The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world treatment outcome of advanced Chinese NSCLC EGFR exon 20 insertion patients.
 
Yan Wang
No Relationships to Disclose
 
Guangjian Yang
No Relationships to Disclose
 
Jun Li
No Relationships to Disclose
 
Haiyan Xu
No Relationships to Disclose
 
Lu Yang
No Relationships to Disclose
 
Fei Xu
No Relationships to Disclose
 
Yaning Yang
No Relationships to Disclose
 
Bing Xia
Consulting or Advisory Role - AstraZeneca; Regeneron
 
Viola Weijia Zhu
Stock and Other Ownership Interests - TP Therapeutics (I)
Honoraria - AstraZeneca; Roche/Foundation Medicine; Roche/Genentech; Takeda
Consulting or Advisory Role - TP Therapeutics
Speakers' Bureau - AstraZeneca; Roche/Foundation Medicine; Roche/Genentech; Takeda
 
Weini Qiu
Employment - Beijing Pengshuweili Technology Co. Ltd.,
Leadership - Beijing Pengshuweili Technology Co Ltd.,
Stock and Other Ownership Interests - Beijing Pengshuweili Technology Co Ltd.,
Travel, Accommodations, Expenses - Beijing Pengshuweili Technology Co Ltd.,
 
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - TP Therapeutics
Honoraria - ARIAD/Takeda; AstraZeneca; Foundation Medicine; Genentech/Roche; Merck; Pfizer; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Foundation Medicine; Ignyta; Pfizer; Roche/Genentech; Takeda; TP Therapeutics
Speakers' Bureau - AstraZeneca; Genentech; Takeda
Research Funding - ARIAD (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Chugai Pharma (Inst); Ignyta (Inst); Pfizer (Inst); Revolution Medicines (Inst); Roche Pharma AG (Inst)